<DOC>
	<DOCNO>NCT01298765</DOCNO>
	<brief_summary>The purpose study determine whether BEMA Buprenorphine safe treatment chronic pain .</brief_summary>
	<brief_title>Longterm Safety Study BEMA Buprenorphine Subjects With Chronic Pain</brief_title>
	<detailed_description>This open label study approximately 52 week duration ass safety effectiveness BEMA Buprenorphine management moderate severe chronic pain . BEMA Buprenorphine oral transmucosal form opioid analgesic , buprenorphine hydrochloride , intend application buccal mucosa . Buprenorphine synthetic opioid classify partial μ-receptor agonist Schedule III control substance United States .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Male nonpregnant nonnursing female age 18 old History moderate severe chronic pain : 1 . Subjects complete study BUP301 ( low back pain ) 2 . Osteoarthritis neuropathic pain , subject complete study BUP301 ( low back pain ) , pain ≥3 month pain intensity ≥5 [ 11 point NRS ] report titration period Day 0/1 visit follow washout period ( opioids , NSAIDs , muscle relaxant ) approximately 12 24 hour AND currently take ≤60 mg oral morphine equivalent/day ( include opioidnaïve ) 1 week longer Stable health , determine Investigator , basis medical history , physical examination , laboratory result comply study procedure Female subject childbearing potential must use recognize effective method birth control Written inform consent obtain prior procedure perform Cancer relate pain Reflex sympathetic dystrophy causalgia ( complex regional pain syndrome ) , acute spinal cord compression , cauda equina compression , acute nerve root compression , meningitis , discitis Surgical procedure pain within 2 month , nerve/plexus block within 4 week , prior titration period Day 0/1 visit History severe emesis opioids Clinically significant sleep apnea judgment investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>buccal soluble film</keyword>
</DOC>